72569-10-9

Basic information

• Product Name: 1-Propanone, 1-(4-hydroxyphenyl)-2,2-dimethyl-
• CAS NO: 72569-10-9
• Molecular Formula: C11H14O2
• Molecular Weight: 178.231
• Mol File: 72569-10-9.mol
• Article Data: 6

Chemical Properties

• CAS DataBase Reference: 1-Propanone, 1-(4-hydroxyphenyl)-2,2-dimethyl-(CAS DataBase Reference)
• NIST Chemistry Reference: 1-Propanone, 1-(4-hydroxyphenyl)-2,2-dimethyl-(72569-10-9)
• EPA Substance Registry System: 1-Propanone, 1-(4-hydroxyphenyl)-2,2-dimethyl-(72569-10-9)

Safety Data

• Hazardous Substances Data: 72569-10-9(Hazardous Substances Data)

Usage

Physical Properties

Colorless, odorless solid

+ Sunless tanning products

reacts with amino acids in the skin to produce a tan-like color
+ Coloring agent in food and beverage industry
+ Reagent in chemical synthesis

Safety

Considered safe and effective, approved by FDA for use in cosmetic products

Industry Applications

Used in cosmetic, food and beverage, and chemical industries

Upstream product

• 27914-73-4 4-acetoxybenzoyl chloride 
• 630-18-2 tert-butyl isocyanide 
• 6793-92-6 p-benzyloxyphenylbromide 

Downstream Products

• 1371591-87-5 tert-butyl 4-(5-{(1R)-1-[4-(2,2-dimethylpropanoyl)phenoxy]propyl}-1,2,4-oxadiazol-3-yl)-2-fluorobenzoate 
• 1371591-89-7 4-(5-{(1R)-1-[4-(2,2-dimethylpropanoyl)phenoxy]propyl}-1,2,4-oxadiazol-3-yl)-2-fluorobenzoic acid 
• 117039-52-8 1-[4-(3-{4-[Bis-(4-fluoro-phenyl)-hydroxy-methyl]-piperidin-1-yl}-propoxy)-phenyl]-2,2-dimethyl-propan-1-one; compound with (E)-but-2-enedioic acid 
• 117022-49-8 1-[4-(3-Chloro-propoxy)-phenyl]-2,2-dimethyl-propan-1-one 

Relevant articles and documents

HCV POLYMERASE INHIBITORS

The invention provides compounds of the formula:wherein B is a nucleobase selected from the groups (a) to (d):and the other variables are as defined in the claims, which are of use in the treatment or prophylaxis of hepatitis C virus infection, and related aspects.

HCV POLYMERASE INHIBITORS

The invention provides compounds of the formula:(I) wherein B is a nucleobase selected from the groups (a) to (d) and the other variables are as defined in the claims, which are of use in the treatment or prophylaxis of hepatitis C virus infection, and related aspects.

ACYLBENZENE DERIVATIVE

Provided are compounds having an excellent hypoglycemic action and a β cell- or pancreas-protecting action or a pharmaceutically acceptable salt thereof, and a pharmaceutical composition having an excellent therapeutic effect and/or prophylactic effect on type 1 diabetes, type 2 diabetes, and the like, which cause an increase in the blood sugar level due to abnormal sugar metabolism. A compound represented by general formula (I), or a pharmaceutically acceptable salt thereof, is disclosed.